Naturhouse Health, S.A. (BME:NTH)
Spain
· Delayed Price · Currency is EUR 2.540
-0.020 (-0.78%)
Apr 29, 2026, 9:02 AM CET
Naturhouse Health Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 10.09 | 9.86 | 11.29 | 9.63 | 13.36 | Upgrade
|
| Depreciation & Amortization | 0.96 | 1.79 | 2.14 | 2.2 | 2.31 | Upgrade
|
| Other Amortization | 0.17 | 0.16 | 0.13 | 0.1 | 0.14 | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.11 | -0.01 | - | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.01 | -0.01 | 0.21 | Upgrade
|
| Loss (Gain) on Equity Investments | -0.18 | -0.47 | 0.15 | -0.31 | -0.59 | Upgrade
|
| Other Operating Activities | 0.9 | 0.98 | 7.12 | -1.22 | 1.33 | Upgrade
|
| Change in Accounts Receivable | 0.27 | 0.07 | -0.11 | 0.31 | 1.33 | Upgrade
|
| Change in Inventory | 0.53 | -0.69 | -0.08 | -0.12 | 0.71 | Upgrade
|
| Change in Accounts Payable | -0.54 | -0.4 | 0.52 | 0.08 | -2.39 | Upgrade
|
| Change in Other Net Operating Assets | -0.16 | 0.28 | -0.22 | -3.56 | -0.23 | Upgrade
|
| Operating Cash Flow | 12.15 | 11.56 | 20.95 | 7.1 | 16.17 | Upgrade
|
| Operating Cash Flow Growth | 5.08% | -44.83% | 195.19% | -56.12% | 10.93% | Upgrade
|
| Capital Expenditures | -0.47 | -0.34 | -0.57 | -0.96 | -0.05 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.25 | 0.19 | 0.05 | - | 0 | Upgrade
|
| Investment in Securities | -0.19 | 1.01 | 0.06 | -4.25 | -4.22 | Upgrade
|
| Investing Cash Flow | -0.42 | 0.86 | -0.46 | -5.22 | -4.27 | Upgrade
|
| Long-Term Debt Issued | - | - | - | 1.02 | - | Upgrade
|
| Long-Term Debt Repaid | -0.95 | -4.1 | -1.7 | - | -2.67 | Upgrade
|
| Net Debt Issued (Repaid) | -0.95 | -4.1 | -1.7 | 1.02 | -2.67 | Upgrade
|
| Common Dividends Paid | -18 | -12 | -6 | -18 | -3.6 | Upgrade
|
| Financing Cash Flow | -18.95 | -16.1 | -7.7 | -16.99 | -6.27 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.03 | -0.03 | -0.52 | -0.04 | - | Upgrade
|
| Net Cash Flow | -7.26 | -3.71 | 12.28 | -15.14 | 5.64 | Upgrade
|
| Free Cash Flow | 11.67 | 11.22 | 20.38 | 6.13 | 16.12 | Upgrade
|
| Free Cash Flow Growth | 4.04% | -44.94% | 232.30% | -61.96% | 12.13% | Upgrade
|
| Free Cash Flow Margin | 24.51% | 22.70% | 40.43% | 11.70% | 27.99% | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.19 | 0.34 | 0.10 | 0.27 | Upgrade
|
| Cash Interest Paid | 0.09 | 0.6 | 0.09 | 0.21 | 0.1 | Upgrade
|
| Cash Income Tax Paid | 3.12 | 3.07 | -2.75 | 6.13 | 4.11 | Upgrade
|
| Levered Free Cash Flow | 16.12 | 7.14 | 20.83 | 4.1 | 14.04 | Upgrade
|
| Unlevered Free Cash Flow | 16.17 | 7.52 | 21.22 | 4.23 | 14.11 | Upgrade
|
| Change in Working Capital | 0.1 | -0.75 | 0.11 | -3.29 | -0.59 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.